Literature DB >> 1693269

Primary retroperitoneal angiosarcoma with eosinophilic globules. A combined light-microscopic, immunohistochemical, and ultrastructural study.

J C Vuletin1, R R Wajsbort, V Ghali.   

Abstract

A poorly differentiated primary retroperitoneal angiosarcoma with abundant intracytoplasmic and extracytoplasmic eosinophilic globules containing alpha 1-antitrypsin and alpha 1-antichymotrypsin is presented. Recognition of these globules may facilitate future diagnoses of the neoplasm in this or other locations. To the best of our knowledge, this is the first article on a primary angiosarcoma of the retroperitoneum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693269

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases.

Authors:  Vikas Mehta; Vijayalakshmi Ananthanarayanan; Tatjana Antic; Thomas Krausz; John Milner; Girish Venkataraman; Maria M Picken
Journal:  Virchows Arch       Date:  2012-10-23       Impact factor: 4.064

2.  Anastomosing hemangioma of the kidney: a literature review of a rare morphological variant of hemangioma.

Authors:  Ayodeji Oluwarotimi Omiyale
Journal:  Ann Transl Med       Date:  2015-07

Review 3.  Anastomosing hemangioma of the kidney: a case report of a rare subtype of hemangioma mimicking angiosarcoma and review of the literature.

Authors:  Ming Zhao; Changshui Li; Jiangjiang Zheng; Ke Sun
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

Review 4.  Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.

Authors:  Tanner Mack; Bibianna Purgina
Journal:  Curr Oncol       Date:  2022-09-07       Impact factor: 3.109

Review 5.  A case report of a renal anastomosing hemangioma and a literature review: an unusual variant histologically mimicking angiosarcoma.

Authors:  Li-Li Tao; Yi Dai; Weihua Yin; Joan Chen
Journal:  Diagn Pathol       Date:  2014-08-08       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.